The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Retracted: An overview of current strategies and future prospects in drug repurposing in tuberculosis”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Geethu S. Kumar, Kuldeep Sharma, Richa Mishra, Esam Ibraheem Azhar, Vivek Dhar Dwivedi, Sharad Agrawal. Overcoming aminoglycoside antibiotic resistance in Mycobacterium tuberculosis by targeting Eis protein, In Silico Pharmacology. 2025; 13: 36. https://doi.org/10.1007/s40203-025-00325-5 |
|
2 |
2024 |
Anuradha Singh, Artificial intelligence for drug repurposing against infectious diseases, Artificial Intelligence Chemistry. 2024; 2: 100071100071. https://doi.org/10.1016/j.aichem.2024.100071 |
|
3 |
2025 |
Elham Amjad, Babak Sokouti. 2025; 305. https://doi.org/10.1016/B978-0-443-22326-6.00024-9 |
|
4 |
2024 |
Amey Deshpande, Rupali Likhar, Tabassum Khan, Abdelwahab Omri. Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges , Expert Review of Anti-infective Therapy. 2024; 22: 511. https://doi.org/10.1080/14787210.2024.2400536 |
|
5 |
2025 |
Sohal Satish, Nachiket Joshi, Rajasekhar Reddy Alavala, Afreen A. Khan. 2025; 965. https://doi.org/10.1007/978-981-96-4154-3_26 |
|
6 |
2025 |
Cemilenur Atas, Tuba Astarcioglu, Kubra Yildirim, Mehmet Akif Gun, Emel Kaynakci, Deniz Turgut Coban, Ahmet Yilmaz Coban. Evaluation of the Activity of Amoxicillin/Clavulanate, Ceftazidime/Avibactam and Colistin Against Drug-Resistant Mycobacterium tuberculosis Isolates by the E-test Method, Jundishapur Journal of Microbiology. 2025; 18: https://doi.org/10.5812/jjm-162034 |